216 related articles for article (PubMed ID: 22253518)
1. Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin.
Ye F; Zhang GH; Guan BX; Xu XC
World J Gastroenterol; 2012 Jan; 18(2):126-35. PubMed ID: 22253518
[TBL] [Abstract][Full Text] [Related]
2. Combination of low concentration of (-)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro and in vivo through causing cell cycle arrest.
Zhou DH; Wang X; Yang M; Shi X; Huang W; Feng Q
Int J Mol Sci; 2013 Jun; 14(6):12023-36. PubMed ID: 23739680
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.
Liu L; Hou L; Gu S; Zuo X; Meng D; Luo M; Zhang X; Huang S; Zhao X
Oncol Rep; 2015 Jan; 33(1):297-303. PubMed ID: 25333353
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
[TBL] [Abstract][Full Text] [Related]
5. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
[TBL] [Abstract][Full Text] [Related]
6. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex.
Lim YC; Cha YY
J Surg Oncol; 2011 Dec; 104(7):776-80. PubMed ID: 21725973
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate inhibits proliferation and migration of human colon cancer SW620 cells in vitro.
Zhou F; Zhou H; Wang T; Mu Y; Wu B; Guo DL; Zhang XM; Wu Y
Acta Pharmacol Sin; 2012 Jan; 33(1):120-6. PubMed ID: 22101170
[TBL] [Abstract][Full Text] [Related]
8. Lovastatin interacts with natural products to influence cultured hepatocarcinoma cell (hep-g2) growth.
Popovich DG; Tiaras F; Yeo CR; Zhang W
J Am Coll Nutr; 2010 Jun; 29(3):204-10. PubMed ID: 20833993
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
Gao Y; Li W; Jia L; Li B; Chen YC; Tu Y
Biochem Biophys Res Commun; 2013 Aug; 438(2):370-4. PubMed ID: 23892041
[TBL] [Abstract][Full Text] [Related]
11. The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
Rieger-Christ KM; Hanley R; Lodowsky C; Bernier T; Vemulapalli P; Roth M; Kim J; Yee AS; Le SM; Marie PJ; Libertino JA; Summerhayes IC
J Cell Biochem; 2007 Oct; 102(2):377-88. PubMed ID: 17348027
[TBL] [Abstract][Full Text] [Related]
12. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
[TBL] [Abstract][Full Text] [Related]
13. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
Shih LJ; Lin YR; Lin CK; Liu HS; Kao YH
Placenta; 2016 May; 41():1-9. PubMed ID: 27208402
[TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Liu L; Ju Y; Wang J; Zhou R
Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of head and neck tumor growth by green tea (-)-epigallocatechin-3-gallate and EGFR tyrosine kinase inhibitor.
Zhang X; Zhang H; Tighiouart M; Lee JE; Shin HJ; Khuri FR; Yang CS; Chen Z'; Shin DM
Int J Cancer; 2008 Sep; 123(5):1005-14. PubMed ID: 18546267
[TBL] [Abstract][Full Text] [Related]
16. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
Kim M; Murakami A; Kawabata K; Ohigashi H
Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
[TBL] [Abstract][Full Text] [Related]
17. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Lee JC; Chung LC; Chen YJ; Feng TH; Chen WT; Juang HH
Cancer Lett; 2015 May; 360(2):310-8. PubMed ID: 25721086
[TBL] [Abstract][Full Text] [Related]
19. Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma.
Spinella F; RosanĂ² L; Di Castro V; Decandia S; Albini A; Nicotra MR; Natali PG; Bagnato A
Mol Cancer Ther; 2006 Jun; 5(6):1483-92. PubMed ID: 16818507
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells.
Kundu JK; Na HK; Chun KS; Kim YK; Lee SJ; Lee SS; Lee OS; Sim YC; Surh YJ
J Nutr; 2003 Nov; 133(11 Suppl 1):3805S-3810S. PubMed ID: 14608118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]